Show all

Investor FAQs

Entera Bio was founded in 2010. 
Entera Bio is headquarterd at: Minrav Building - Fifth Floor 
Kiryat Hadassah 
Jerusalem 9112002, Israel 
 
Entera Bio shares trade on the NASDAQ Capital Market under the symbol "ENTX" for our ordinary shares and "ENTXW" for our warrants.
Entera Bio does not offer a direct stock purchase program.
Entera Bio’s fiscal year ends on December 31.
Entera Bio’s SEC filings, including its annual report, quarterly earnings releases and other investor materials are available under the “Investors” section of our corporate website.  Additionally, all SEC filings can also be accessed directly from the SEC’s website at www.sec.gov.
Entera Bio does not anticipate paying any cash dividends in the foreseeable future.
The transfer agent and registrar for Entera Bio is

American Stock Transfer & Trust

6201 15th Avenue
Brooklyn, NY 11219
United States
Phone: 718-921-8200
Fax: 718-236-2641
Website Address: www.astfinancial.com
Email: help@astfinancial.com
InvestorRelations@Enterabio.com

Investor FAQs